Carboni, Johnathon
Thomas, Elizabeth
Gipson, Debbie S.
Brady, Tammy M.
Srivastava, Tarak
Selewski, David T.
Greenbaum, Larry A.
Wang, Chia-shi
Dell, Katherine M.
Kaskel, Frederick
Massengill, Susan
Reidy, Kimberly
Tran, Cheryl L.
Trachtman, Howard
Lafayette, Richard
Almaani, Salem
Hingorani, Sangeeta
Gbadegesin, Rasheed
Gibson, Keisha L.
Sethna, Christine B. http://orcid.org/0000-0001-7154-6308
Dell, K.
Sedor, J.
Schachere, M.
Negrey, J.
Lemley, K.
Scott, J.
Srivastava, T.
Morrison, S.
Sethna, C.
Pfaiff, M.
Canetta, P.
Pradhan, A.
Greenbaum, L.
Wang, C.
Yun, E.
Adler, S.
LaPage, J.
Athavale, A.
Itteera, M.
Atkinson, M.
Dell, T.
Fervenza, F.
Hogan, M.
Lieske, J.
Hill, G.
Kaskel, F.
Ross, M.
Flynn, P.
Kopp, J.
Malaga-Dieguez, L.
Zhdanova, O.
Modersitzki, F.
Pehrson, L.
Lafayette, R.
Yeung, B.
Lee, I.
Quinn-Boyle, S.
Reich, H.
Hladunewich, M.
Ling, P.
Romano, M.
Fornoni, A.
Bidot, C.
Kretzler, M.
Gipson, D.
Williams, A.
Klida, C.
Derebail, V.
Gibson, K.
Froment, A.
Ochoa-Toro, F.
Holzman, L.
Meyers, K.
Kallem, K.
Swenson, A.
Sambandam, K.
Aleman, K.
Rogers, M.
Jefferson, A.
Hingorani, S.
Tuttle, K.
Manahan, L.
Pao, E.
Cooper, A.
Lin, J. J.
Baker, Stefanie
Kretzler, M.
Barisoni, L.
Gadegbeku, C.
Gillespie, B.
Gipson, D.
Holzman, L.
Mariani, L.
Sampson, M.
Sedor, J.
Zee, J.
Alter, G.
Desmond, H.
Eddy, S.
Fermin, D.
Larkina, M.
Li, S.
Lienczewski, C. C.
Mainieri, T.
Scherr, R.
Smith, A.
Szymanski, A.
Williams, A.
Avila-Casado, Carmen
Bagnasco, Serena
Gaut, Joseph
Hewitt, Stephen
Hodgin, Jeff
Lemley, Kevin
Mariani, Laura
Palmer, Matthew
Rosenberg, Avi
Royal, Virginie
Thomas, David
Zee, Jarcy
Barisoni, Laura
Nast, Cynthia
,
Funding for this research was provided by:
National Center for Advancing Translational Sciences (U54DK083912)
University of Michigan
Nephcure Foundation
National Institute of Neurological Disorders and Stroke (U2CTR002818)
National Institute of Diabetes and Digestive and Kidney Diseases (R01DK131091)
NHLBI Division of Intramural Research (1R01HL162912-01A1)
Article History
Received: 25 September 2023
Revised: 4 January 2024
Accepted: 5 January 2024
First Online: 6 February 2024
Declarations
:
: NEPTUNE was approved by the Institutional Review Board at each participating site and written informed consent/assent was obtained from each participant. This study protocol was reviewed and approved by University of Michigan Medical School (IRBMED), approval number HUM00158219.
: Christine Sethna has been on an advisory board for Travere Therapeutics. Larry Greenbaum receives research support from Alexion, Advicenne, Abbvie, Apelis, Aurinia, Reata Pharmaceuticals, Vertex, Roche, and Otsuka; Larry Greenbaum provides consulting for Novartis, Alexion, Roche, Aurinia, and Otsuka. Chia-shi Wang receives research support from the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) under Award Number K23DK118189, NephCure Kidney International (NKI), Boehringer-Ingelheim, and IQVIA outside the submitted work. Richard Lafayette provides consulting for Alexion, GSK, Aurinia, Calliditas, Chinook, Vera, Novartis, Omeros, Chemocentryx, Travere; Richard Lafayette receives research support from Alexion, Calliditas, Chinook, Vera, Novartis, Omeros, Chemocentryx, Travere, Roche, and Pfizer. Tarak Srivastava has received research funding from Roche, Apellis Pharmaceuticals, and Travere Therapeutics. The other authors have no relevant conflicts to disclose.